Close Menu

The New York Times' Steve Lohr reports at the Bits blog that IBM is using Watson-style software as part of it's "Strategic Intellectual Property Insight Platform," a cloud-based service resulting from "several years of joint development between IBMResearch and four companies — AstraZeneca, Bristol-Myers Squibb, DuPont, and Pfizer." Lohr says the platform "uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical jo

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.